Sea Change In Medtech As Industry Leans To US For New Innovation
Reimbursement has become a major obstacle to innovation
An expansive study shows the US has emerged over Europe as the preferred launch site for new medical technology because the Food and Drug Administration responds more effectively to innovation than do European regulators.
